Methods Applied to Assess Real‐World Effectiveness of Drugs: A Scoping Review
Pharmacology Research & Perspectives · 2026
DOI: 10.1002/prp2.70244 ↗Kurz gefasst
Scoping Review in der Zeitschrift Pharmacology Research & Perspectives, 2026. Verfasst von Benedikte Irene von Osmanski und 5 weiteren Autor:innen. Beteiligte Einrichtung: Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebj…. Hauptthemen laut MEDLINE: Pharmacoepidemiology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovationsfonden.
Abstract (Originalsprache)
Drug effectiveness evaluations are needed to bridge the gap between premarketing trials and clinical practice, but the specific methods used in such evaluations remain unclear. Therefore, this review aimed to identify pharmacoepidemiological effectiveness studies based on real‐world data (RWD) and categorize them based on the methods applied and the drugs and outcomes investigated. We searched PubMed and Embase for relevant records published in the period July–December 2019. Eligible studies: (i) were RWD‐based; (ii) evaluated one or multiple drug exposures, and (iii) included at least one effectiveness outcome (as primary outcome). Among 4820 identified records, 1129 passed title‐abstract screening, 200 were randomly selected for full‐text assessment, and 87 were ultimately included. Of these, 55 included > 1000 patients, 22 included > 10 000 patients, and 22 explicitly restricted to new users. Chemotherapy was the most common exposure ( n = 32), all‐cause mortality the most prevalent outcome ( n = 52), and non‐use of the exposure drug ( n = 42) the most frequent comparator category. Survival models ( n = 55) were the dominating statistical models, and 13 studies used only descriptive statistics. In conclusion, well‐known pharmacoepidemiological methods were applied in the included studies, and many had large study populations. Common limitations were use of simple descriptive statistics and absence of active comparators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark.
- Signum Life Science, Copenhagen, Denmark.
- Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
- Amgros, Copenhagen, Denmark.
- Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.
- Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Benedikte Irene von Osmanski, Mikkel Zöllner Ankarfeldt
Förderung
- Innovationsfonden
Zitieren
APA
von Osmanski, B. I., Petersen, J., Petersen, C. T., Bentsen, A. H., Jimenez-Solem, E., & Ankarfeldt, M. Z. (2026). Methods Applied to Assess Real‐World Effectiveness of Drugs: A Scoping Review. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70244
Vancouver
von Osmanski BI, Petersen J, Petersen CT, Bentsen AH, Jimenez-Solem E, Ankarfeldt MZ. Methods Applied to Assess Real‐World Effectiveness of Drugs: A Scoping Review. Pharmacology Research & Perspectives. 2026. doi:10.1002/prp2.70244
BibTeX
@article{vonOsmanski2026,
author = {von Osmanski, Benedikte Irene and Petersen, Janne and Petersen, Charlotte Thor and Bentsen, Andreas Høiberg and Jimenez-Solem, Espen and Ankarfeldt, Mikkel Zöllner},
title = {Methods Applied to Assess Real‐World Effectiveness of Drugs: A Scoping Review},
journal = {Pharmacology Research & Perspectives},
year = {2026},
doi = {10.1002/prp2.70244}
}
EUVIMED